Exploring 3 Promising Undervalued Small Caps In Global With Insider Action

Yahoo FinanceNov 14 17:39

China Galaxy Securities: Reiterates 'Outperform' Rating for Innovent Bio, Highlighting Breakthrough in Comprehensive Pipeline to Drive Second Growth Curve

China Galaxy Securities released a research report stating that Innovent Bio (01801) has become a leading domestic Biopharma company integrating innovative drug research and development, production, and commercialization. Its leading position in the oncology field remains solid, continuously driving growth; breakthroughs in its comprehensive pipeline have established a second growth curve, providing room for long-term development. The firm forecasts the company’s revenue for 2025-2027 to reach RMB 11.891 billion, RMB 14.836 billion, and RMB 20.029 billion, respectively, with net profits attributable to shareholders at RMB 824 million, RMB 1.378 billion, and RMB 2.059 billion, respectively. It maintains a “Buy” rating. China Galaxy Securities’ main view...

Sina HK StocksNov 14 16:40

Hong Kong Stock Market Close | Divergence in Weekly Performance of Major Indices; Ascletis Pharma Surges Over 40%

① What are the potential ripple effects of recent hawkish statements by Fed officials on the liquidity of gold stocks and the overall Hong Kong stock market? ② Why did Superstar Legend decline this week?

cls.cnNov 14 16:36

China Galaxy Securities: Initiate China Tower with a 'Buy' rating; leading position in 'one body, two wings' strategy highlights scale effects.

China Galaxy Securities released a research report stating that it is covering China Tower (00788) for the first time and assigning it a “Buy” rating. The company leads in its “One Body, Two Wings” strategy with significant economies of scale. The brokerage forecasts that the company’s net profits attributable to shareholders for 2025-2027 will reach RMB 11.629 billion, RMB 16.097 billion, and RMB 17.435 billion, respectively, corresponding to EPS of RMB 0.66, RMB 0.91, and RMB 0.99 (considering the short-term substantial boost to net profit due to the expiration of depreciation on existing towers by 2026). China Galaxy Securities’ key points are as follows: China Tower – the global leader in telecommunications infrastructure, focusing on the “One Body, Two Wings” strategy. In July 2014...

Sina HK StocksNov 14 14:44

Broker Morning Meeting Highlights: AI Investment Opportunities Expand, Focus on Computing Power Industry Chain and AI Applications

At today's morning meeting of securities firms, Huatai Securities stated that the GMV of e-commerce during the 'Double Eleven' period may see moderate growth, with continued divergence in platform performance; Galaxy Securities noted that the overall price and premium rate of convertible bonds have risen to high levels, necessitating appropriate control of downside risks; CITIC Securities believes that AI investment opportunities are expanding, with a focus on the computing power industry chain and AI applications.

cls.cnNov 14 08:39

China Galaxy Securities Monetary Policy Outlook: The monetary policy in 2026 will continue with a moderately accommodative tone, but the path of easing will change.

Gelonghui, November 14th | Galaxy Securities released its monetary policy outlook: the monetary policy in 2026 will continue with a moderately loose tone, but the path of easing will change. It is expected that China's economy will maintain stable growth in 2026, and prices will also show a mild recovery trend. Meanwhile, the RMB exchange rate will exhibit steady appreciation. Against this backdrop, the primary objectives of monetary policy will be full employment and financial stability. The path of monetary easing will unfold around three main themes: stabilizing expectations, preventing risks, and coordinating with fiscal policy. Looking ahead to 2026, it is anticipated that the policy interest rate will be lowered by 10-20 basis points (BP) for the entire year, and the transmission of monetary policy will be enhanced.

Gelonghui FinanceNov 14 08:27